Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test

 Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test

Shots:

  • The Phenomix’s MyPhenome test utilize phenotype-driven multi-omics technology to analyze genomics, metabolomics, and hormone levels and use AI-driven algorithmic tool to identify four specific obesity phenotypes, giving doctors the ability to prescribe more precise anti-obesity treatments
  • The study showed that phenotype-specific obesity resulted in nearly double the weight loss over the treatment course of 1yr.
  • Phenomix has identified the four primary phenotypes i.e Hungry Brain, Hungry Gut, Emotional Hunger, and Slow Burn that encompass more than 90% of obesity cases. The company expects the launch of the MyPhenome test in 2021, once its CLIA laboratory process is complete

Click here to­ read full press release/ article | Ref: BUSINESS WIRE | Image: Phenomix

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post